Baradaran Seyed, Z. (1400). Evidence-Based Approach to One Health Vaccinology. سامانه مدیریت نشریات علمی, 76(6), 1575-1577. doi: 10.22092/ari.2021.357232.2004
Z Baradaran Seyed. "Evidence-Based Approach to One Health Vaccinology". سامانه مدیریت نشریات علمی, 76, 6, 1400, 1575-1577. doi: 10.22092/ari.2021.357232.2004
Baradaran Seyed, Z. (1400). 'Evidence-Based Approach to One Health Vaccinology', سامانه مدیریت نشریات علمی, 76(6), pp. 1575-1577. doi: 10.22092/ari.2021.357232.2004
Baradaran Seyed, Z. Evidence-Based Approach to One Health Vaccinology. سامانه مدیریت نشریات علمی, 1400; 76(6): 1575-1577. doi: 10.22092/ari.2021.357232.2004
Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran
چکیده
Only a few human vaccine trials have been reported from the least developed countries. The target population of biological products often does not have the same opportunity to participate in pre-and post-licensing studies (1). The COVID-19 vaccine trials may have been exceptional. At the same time, in many developing countries, biopharmaceutical research and development have not been pursued with the same vigor as other pharmaceutical industries. For example, despite a century of history of the vaccine industry in a country like Iran, the allocated budget and established infrastructures in the contemporary have not been parallel to other fields of the pharmaceutical industry. On a global scale, the progress of the animal vaccine industry is not comparable to that of humans. A detailed comparative review of human and animal vaccine research methodology revealed that the concepts are not apparent in the animal sector (2). Accordingly, the terminology and assessment of animal vaccines should be standardized and strictly applied. A surveillance system that follows up on vaccines and adverse reaction information is an exemplary human benefit. Although, in many cases, there is no such infrastructure in the animal sector, so it is not possible, to a certain extent, to assess the safety and effectiveness information of approved animal vaccines.
Grenham A, Villafana T. Vaccine development and trials in low and lower-middle income countries: Key issues, advances and future opportunities. Human vaccines & immunotherapeutics. 2017;13(9):2192-9.
Knight-Jones T, Edmond K, Gubbins S, Paton D. Veterinary and human vaccine evaluation methods. Proceedings of the Royal Society B: Biological Sciences. 2014;281(1784):20132839.
Brace S, Taylor D, O'Connor AM. The quality of reporting and publication status of vaccines trials presented at veterinary conferences from 1988 to 2003. Vaccine. 2010;28(32):5306-14.
Sargeant JM, Deb B, Bergevin MD, Churchill K, Dawkins K, Dunn J, et al. Efficacy of bacterial vaccines to prevent respiratory disease in swine: a systematic review and network meta-analysis. Animal health research reviews. 2019;20(2):274-90.
Arega SM, Knobel DL, Toka FN, Conan A. Non-specific effects of veterinary vaccines: a systematic review. Vaccine. 2021.
Benn CS, Fisker AB, Rieckmann A, Sørup S, Aaby P. Vaccinology: time to change the paradigm? The Lancet Infectious Diseases. 2020.
Monath TP. Vaccines against diseases transmitted from animals to humans: a one health paradigm. Vaccine. 2013;31(46):5321-38.
8. Warimwe GM, Francis MJ, Bowden TA, Thumbi SM, Charleston B. Using cross-species vaccination approaches to counter emerging infectious diseases. Nature Reviews Immunology. 2021:1-8.